Postherpetic neuralgia in older adults: Culture, quality of life, and the use of alternative/complementary therapies

Holistic Nursing Practice

Volumn 21, Issue 3, 2007, Pages 124-134

  Young, Michele K ^a   Wood, Madetric ^a   Jean Noel, Natacha ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Alternative complementary therapy; Culture; Older adults; Postherpetic neuralgia; Quality of life

Indexed keywords

AGING; ALTERNATIVE MEDICINE; ATTITUDE TO HEALTH; CULTURAL FACTOR; EVIDENCE BASED MEDICINE; HERPES ZOSTER; HOLISTIC NURSING; HUMAN; NEURALGIA; NURSING; QUALITY OF LIFE; REVIEW; UTILIZATION REVIEW;

AGING; COMPLEMENTARY THERAPIES; CULTURAL CHARACTERISTICS; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERPES ZOSTER; HOLISTIC NURSING; HUMANS; NEURALGIA; QUALITY OF LIFE;

EID: 34247891498     PISSN: 08879311     EISSN: 15505138     Source Type: Journal    
DOI: 10.1097/01.HNP.0000269149.80978.15     Document Type: Review

References (41)

1. Mounsey AL, Matthew LG, Slawson DC. Herpes zoster and post herpetic neuralgia: prevention and management. Am Fam Physician. 2005;72(6):1075-1080.
2. Lee VK, Simpkins L. Herpes zoster and postherpetic neuralgia in the elderly. Geriatr Nurs. 2000;21:132-135.
3. Munoz C, Hilgenberg C. Ethnopharmacology. Am J Nurs. 2005;105(8):41-48.
4. Rice ASC, Maton S. Gabapentin in post herpetic neuralgia: a randomized, double blind, placebo controlled study. Pain. 2001;94:215-224.
5. Seventer RV, Sadosky A, Lucero M, Dukes E. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing. 2006;35(2):132-137.
6. Douglas MW, Johnson RW, Cunningham AL. Tolerability of treatments for postherpetic neuralgia. Drug Saf. 2004;27(15):1217-1233.
7. Niv D, Devor M. Refractory neuropathic pain: the nature and extent of the problem. Pain Pract. 2006;6(1):3-9.
8. Centers for Disease Control. Considerations for shingles vaccine recommendations in the U.S. Shingles Working Group Advisory Committee on Immunization Practices. Available at: http://www.cdc. gov/nip/ACIP/slides/jun06/ shingles-4-treanor.pdf. Accessed October 3, 2006.
9. Merriam-Webster's Medical Dictionary. Springfield, Mass: Merriam-Webster Inc; 1995.
10. Baron R. Post-herpetic neuralgia case study: optimizing pain control. Eur J Neurol. 2004;11(1):3-11.
11. Nordenson NJ. Tzanck preparation. Available at: http://www.healthatoz. com/healthatoz/Atoz/ency/tzanck_preparation.jsp. Accessed October 14, 2006.
12. Helgasson S, Petursson G, Gudmundsson S, Sigmundson JA. Prevalence of post herpetic neuralgia after a first episode of herpes zoster: retrospective study with long-term follow-up. BMJ. 2000;321(7264):794-796.
13. Kochar DK, Gag P, Bomb RA, et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebocontrolled study. Q J Med. 2005;9:29-34.
14. Ammer K, Schartelmueller T, Melnizky P. Thermal imaging in acute herpes zoster or post-zoster neuralgia. Skin Res Technol. 2001;7:219-222.
15. Rabey MI. Post-herpetic neuralgia: possible mechanisms for pain relief with manual therapy. Man Ther. 2003;8(3):180-184.
16. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of post herpetic neuralgia. An evidence-based report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2003;63:959-965.
17. Scott FT, Leedham-Green ME, Barrett-MuirWY, et al. A study of shingles and the development of postherpetic neuralgia in east London. J Med Virol. 2003;70:S24-S30.
18. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in post herpetic neuralgia: a randomized, placebocontrolled trial. Neurology. 2002;59(7):1015-1021.
19. Wright WL. Diagnosis and treatment of herpes zoster: role of the nurse practitioner. J Am Acad Nurse Pract Suppl. 2003;15(12):10-15.
20. Katz J, McDermott MP, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster. J Pain. 2005;6(12):782-790.
21. Meadows M. FDA issues guidance on race and ethnicity data. Available at: http://www.fda.gov/fdac/features/2003/303_race.html. Accessed October 10, 2006.
22. Polit DE, Beck CT. Nursing Research Principles and Methods. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
23. Volpi A, Gross G, Hercogovan J, Johnson RW. Current management of herpes zoster: the European view. Am J Clin Dermatol. 2005;6(5):317-325.
24. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 2006;122:156-162.
25. Gross G, Schofer H, Wassilew S, et al. Herpes zoster guideline of the German Dermatology Society. J Clin Virol. 2003;26:277-289.
26. Arita H, Hayashida M, Hanaoka K. Pain control for elderly patients in Japan. Geriatr Gerontol Int. 2004;4:S239-S241.
27. Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use and health-related quality of life in older persons with post herpetic neuralgia: results from a population-based study. J Pain. 2005;6:356-363.
28. Stein D, Rocco TS, Goldenetz KA. Age and the university workplace: a case study of remaining, retiring, or returning older workers. Hum Resour Dev Q. 2000;11(1):61-80.
29. Dault RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17:197-210.
30. EuroQoL Group. EuroQoL-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
31. Katz NP, Gammaitoni AR, Davis MW, Dworkin RH. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with post herpetic neuralgia: an effectiveness trial. Pain Med. 2002;3:324-332.
32. Stewart AL, Hays RD, Ware JE. The MOS Short-Form General Health Survey. Med Care. 1988;26:724-735.
33. Beck AT, Ward CH, Mendelson M, Mock J, Erlbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
34. Spielberger CD. State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1977.
35. Greenway FL, Frome BM, Engels TM, McLellan A. Temporary relief of post herpetic neuralgia pain with topical geranium oil. Am J Med. 2003;115:586-587.
36. Davies SJ, Harding LM, Baranowski AP. A novel treatment of postherpetic neuralgia using peppermint oil. Clin J Pain. 2002;18:200-202.
37. Liu H, Tsai S, Kao M, Hu JS. Botulinum toxin a relieved neuropathic pain in a case of post-herpetic neuralgia. Pain Med. 2006;7(1):89-91.
38. Williamson A. A case of post-herpetic neuralgia treated with selfhypnosis and imagery. Contemp Hypn. 2004;22(3):146-149.
39. Klein AW. The therapeutic potential of botulinum toxin. Dermatol Surg. 2004;30:452-455.
40. National Institutes of Health. NIDA infofacts: club drugs. 2006. Available at: http://www.nida.nih.gov/Infofacts/clubdrugs.html. Accessed November 7, 2006.
41. Carruthers J, Carruthers A. Botox-beyond wrinkles. Clin Dermatol. 2004;22(1):89-93.